Synedica Semaglutide® Injection Pen Kit is the world’s most advanced weight loss solution. Commonly known as “Ozempic,” semaglutide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of GLP-1, a natural hormone that makes humans feel full from eating much smaller portions of food.

The Synedica Semaglutide® 1mg Injection Pen Kit contains 2 pens, 12 disposable needles and an instruction booklet.

Each pen has 4mg which can be delivered across 4 full doses of 1mg, or in increments of 0.25mg, 0.5mg, 0.75mg or 1mg.

Recommended dosage is 0.25mg for the first 4 weeks, then 0.5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 0.75mg or 1mg.

⚠️ Important Notice
All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

🔬 Suitable R&D Applications
 

🧪 Stability Testing
Thermal, enzymatic, and oxidative degradation studies

Shelf-life evaluation & formulation robustness

⚗️ Formulation Development
Enhances solubility, bioavailability, and structural integrity

Tailored for injectable, topical, and research-grade use

🧩 Excipient Compatibility Testing
Evaluates interactions between peptides & inactive components

Ensures safety, stability, and performance

🔒 Protease Resistance Evaluation
Assesses susceptibility to enzymatic breakdown

Supports development of more durable peptide products

📦 Encapsulation & Carrier Systems
Liposomes, microspheres, and other delivery vehicles

Protects peptides & enables controlled release

💉 Administration Route Assessment
Optimized for:

Parenteral delivery (injectables)

Dermal absorption (cosmetic/topical)

In vitro research applications